Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a $14.9 million net loss and used $15.4 million in operating cash during the ...

Q2 2025 Earnings Call Transcript August 5, 2025 Operator: Good morning or good afternoon all, and welcome to the Ingevity Q2 ...

In fact, EPR has outperformed the S&P 500 benchmark index by more than 50 percentage points over the past five years, and its performance translates to an annualized return of about 21%.

Explore Ingevity Corporation's Q2 2025 performance, including margin growth, enhanced guidance, and strategic portfolio updates positioning for ...

Forget the old adage that aging is a slow, steady decline. Recent scientific research is rewriting the rules, suggesting that ...

Published in The Lancet, researchers analyzed data from 57 studies across 35 cohorts, covering everything from heart disease to fall risk. They found that increasing your daily steps—especially from ...

I have watched with interest the negative attacks in response to the American Eagle ad featuring actress Sydney Sweeney ...